As many companies in France and in the world, the COVID-19 pandemic deeply affects our activities. For safety reasons, most of our work is now done remotely but we maintain essential activity in laboratories to take care of our cells and try to finish our ongoing customer studies.

The situation is complex and very unstable, so we cannot promise to meet the expected deadlines. However, we are still open to plan your next studies!

For BIOMIMESYS® plates, the production still goes on and you can order them as usual. Of course expeditions could be impacted in the near future, but at the moment everything goes well.

Every problem is also an opportunity: it is the perfect moment to talk about our future needs, to imagine together our next in vitro studies, to build with you a new BIOMIMESYS® that fits 100% with your research!

Contact us, we are available!


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

0 Comments

Leave a Reply